Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels

被引：11
|
作者：
Lujan, Juliana Velez [1 ]
Lengerke-Diaz, Paula A. [2 ]
Jacobs, Chaja [1 ]
Moreno-Cortes, Eider F. [2 ]
Ramirez-Segura, Cesar A. [2 ]
Choi, Michael Y. [1 ]
McCarthy, Colin [1 ]
Heinen, Alaina [1 ]
Kipps, Thomas J. [1 ]
Castro, Januario E. [1 ,2 ]
机构：
[1] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA
[2] Mayo Clin, Scottsdale, AZ USA
来源：
HAEMATOLOGICA | 2020年 / 105卷 / 01期
关键词：
MONOCLONAL-ANTIBODY; CLL PATIENTS; CHLORAMBUCIL; RELEASE;
D O I：
10.3324/haematol.2018.212597
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E22 / E25
页数：4
相关论文
共 50 条
  • [21] Pre-treatment with Idelalisib markedly reduces Rituximab infusion-related reactions and infusion interruptions in patients with CLL
    Hallek, M.
    Hillmen, P.
    Furman, R. R.
    Coutre, S. E.
    Sharman, J. P.
    Pagel, J. M.
    Barrientos, J. C.
    Zelenetz, A. D.
    Kipps, T. J.
    Flinn, I. W.
    Ghia, P.
    Eradat, H.
    Erwin, T.
    Lamanna, N.
    Coiffier, B.
    Pettitt, A. R.
    O'Brien, S. M.
    Cheson, B. D.
    Ruppert, S.
    Kroenig, H.
    Schuster, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 52 - 53
  • [22] Infusion-related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels
    Arning, M
    Kliche, KO
    HeerSonderhoff, AH
    Wehmeier, A
    [J]. MYCOSES, 1995, 38 (11-12) : 459 - 465
  • [23] Rapid improvement in symptoms and physical function following ibrutinib initiation in chronic lymphocytic leukemia and the associated changes in plasma cytokines
    Ishdorj, G.
    Nugent, Z.
    Squires, M.
    Kost, S.
    Banerji, V.
    Davidson, L.
    Katyal, C. S.
    Marshall, A.
    Gibson, S. B.
    Johnston, J. B.
    [J]. LEUKEMIA RESEARCH, 2021, 109
  • [24] Long-Term Sustained Responses Following Ibrutinib Discontinuation after Frontline Therapy with Obinutuzumab Plus Ibrutinib in Patients with Chronic Lymphocytic Leukemia
    Diaz, Paula A. Lengerke
    Choi, Michael Y.
    Cortes, Eider F. Moreno
    Forero, Jose V.
    Velez-Lujan, Juliana
    Amaya-Chanaga, Carlos I.
    Kipps, Thomas
    Castro, Januario E.
    [J]. BLOOD, 2020, 136
  • [25] Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients
    Cassin, Ramona
    Visentin, Andrea
    Giannarelli, Diana
    Noto, Alessandro
    Mauro, Francesca Romana
    Baldini, Luca
    Trentin, Livio
    Reda, Gianluigi
    [J]. HEMATOLOGICAL ONCOLOGY, 2021, 39 (01) : 141 - 144
  • [26] Cost-Effectiveness of Ibrutinib Compared With Obinutuzumab With Chlorambucil in Untreated Chronic Lymphocytic Leukemia Patients With Comorbidities in the United Kingdom
    Sinha, Richa
    Redekop, William Ken
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (02): : E131 - E142
  • [27] Cytokine release in patients treated with obinutuzumab, a glycoengineered type II anti-CD20 antibody and possible relationship with development of infusion related reactions in patients with chronic lymphocytic leukaemia
    Freeman, C.
    Morschhauser, F.
    Fingerle-Rowson, G.
    Lei, G.
    Wassner-Fritsch, E.
    Cartron, G.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 : 70 - 70
  • [28] Ruxolitinib Reduces Cytokine/Chemokine Levels and Improves Fatigue and Chronic Lymphocytic Leukemia (CLL)-Related Symptoms in CLL Patients Not Requiring Systemic Therapy
    Jain, Preetesh
    Keating, Michael J.
    Cleeland, Charles
    Renner, Sarah
    Huang Xuelin
    Gonzalez, Graciela Nogueras
    Harris, David M.
    Wierda, William
    DiNardo, Courtney
    Pemmaraju, Naveen
    Jain, Nitin
    Thompson, Philip
    Ferrajoli, Alessandra
    Burger, Jan A.
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    Estrov, Zeev
    [J]. BLOOD, 2015, 126 (23)
  • [29] Safe administration of rituximab in patients with chronic lymphocytic leukemia and a history of obinutuzumab-associated anaphylaxis
    Salomon-Perzynski, Aleksander
    Konska, Agnieszka
    Zawirska, Daria
    Lech-Maranda, Ewa
    Jamroziak, Krzysztof
    [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (7-8): : 494 - 495
  • [30] Evaluation of cytokine levels as possible predicting elements in patients with chronic lymphocytic leukemia
    Khodashenas, Maryam
    Rajabian, Arezoo
    Attaranzadeh, Armin
    Arab, Fahimeh Lavi
    Allahyari, Negin
    Allahyari, Abolghasem
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (10): : 1364 - 1368
12345